Results 241 to 250 of about 210,768 (294)
Some of the next articles are maybe not open access.

Related searches:

PSORIASIS AND ALPHA-INTERFERON

Lancet, The, 1986
Two patients with metastatic renal carcinoma who were treated with recombinant-DNA-derived alpha-interferon (rIFN alpha) had exacerbation of concomitant psoriasis, and another patient experienced onset of psoriasis during treatment with rIFN alpha. This suggests that interferons may participate in the pathophysiology of psoriasis.
J R Quesada, J U Gutterman
exaly   +3 more sources

Interferon-alpha hybrids

Pharmacology & Therapeutics, 1995
The alpha-interferons (IFN-alpha) belong to a family of polypeptides comprising several subtypes. Using recombinant DNA technology, it has been possible to create IFN hybrids that provide novel combinations of the amino acid residues from the parental protein sequences.
M A, Horisberger, S, Di Marco
openaire   +2 more sources

The New Alpha Interferons

Drug Intelligence & Clinical Pharmacy, 1985
Alpha interferons are biological response modifiers that regulate immune function, slow cell proliferation, and inhibit virus replication. Large supplies of purified preparations are now available for clinical trials. Common toxicity includes an influenza-like syndrome to which tolerance occurs after several doses, and chronic fatigue and anorexia that
Carol McManus Balmer, Donald C. McLeod
openaire   +2 more sources

The interferon-alpha revival in CML

Annals of Hematology, 2015
Interferon-alpha (IFNα) was once the standard of frontline treatment for chronic myeloid leukemia (CML). Its pleiotropic mechanism of action in CML includes immune activation and specific targeting of CML stem cells. Early studies of IFNα in CML demonstrated that patients in chronic phase could attain extremely stable remissions, which correlated with ...
Moshe, Talpaz   +2 more
openaire   +2 more sources

Interferon alpha in lymphoma

British Journal of Haematology, 1991
A number of studies are currently in progress to evaluate the use of interferon alpha, alone and in combination with conventional chemotherapy in patients with follicular lymphoma. The background to these is reviewed, together with currently available data about the potential role of interferon alpha in cutaneous T cell lymphoma.
openaire   +2 more sources

Induction of interferon-alpha by interferon-beta, but not of interferon-beta by interferon-alpha, in the mouse.

Virology, 1990
The antigenicity of the interferon (IFN) produced in transgenic mice carrying an extra mouse IFN-beta gene under the control of mouse metallothionein-I enhancer-promoter was examined after induction with Cd2+. Unexpectedly, IFN-alpha in addition to IFN-beta was detected in the serum.
M, Asano   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy